Free Trial

NovelStem International Q1 2024 Earnings Report

NovelStem International logo
$0.0090 0.00 (0.00%)
As of 04/3/2025

NovelStem International EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NovelStem International Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NovelStem International Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Remove Ads

NovelStem International Earnings Headlines

Glencore International
Trump’s Final Plan
Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’s secret plan to trigger the greatest transfer of wealth since FDR and LBJ – trillions of dollars could be redistributed.
NovelStem International Corp. (NSTM)
See More NovelStem International Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NovelStem International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NovelStem International and other key companies, straight to your email.

About NovelStem International

NovelStem International (OTCMKTS:NSTM), a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.

View NovelStem International Profile

More Earnings Resources from MarketBeat